Cargando…

Prediction of key gene function in spinal muscular atrophy using guilt by association method based on network and gene ontology

Guilt by association (GBA) algorithm has been widely used to predict gene functions statistically, and a network-based approach may increase the confidence and veracity of identifying molecular signatures for diseases. The aim of the present study was to suggest a gene ontology (GO)-based method by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wenjiu, Han, Jing, Ma, Jinfeng, Feng, Yujie, Hou, Qingxian, Wang, Zhijie, Yu, Tengbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425128/ https://www.ncbi.nlm.nih.gov/pubmed/30906446 http://dx.doi.org/10.3892/etm.2019.7216

Ejemplares similares

Gene therapy for spinal muscular atrophy: the Qatari experience
por: Ali, Hossamaldein Gaber, et al.
Publicado: (2021)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Gene therapy for spinal muscular atrophy: the benefit–cost profile
Publicado: (2021)

Commentary: Current Status of Gene Therapy for Spinal Muscular Atrophy
por: Rossoll, Wilfried, et al.
Publicado: (2022)

Investigation on the Effects of Modifying Genes on the Spinal Muscular Atrophy Phenotype
por: Zhuri, Drenushe, et al.
Publicado: (2022)

Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2016)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis
por: Wang, Junjie, et al.
Publicado: (2021)

Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy.
por: Shin, S., et al.
Publicado: (2000)

Drugs, genes and screens: The ethics of preventing and treating spinal muscular atrophy
por: Gyngell, Christopher, et al.
Publicado: (2019)

Gene therapy for spinal muscular atrophy: Solomon's consensus in Covid times
por: Zafeiriou, Dimitrios
Publicado: (2020)

25 years of the SMN genes: the Copernican revolution of spinal muscular atrophy
por: Tiziano, Francesco Danilo, et al.
Publicado: (2020)

Structural Context of a Critical Exon of Spinal Muscular Atrophy Gene
por: Singh, Natalia N., et al.
Publicado: (2022)

Combining guilt-by-association and guilt-by-profiling to predict Saccharomyces cerevisiae gene function
por: Tian, Weidong, et al.
Publicado: (2008)

How to improve the safety of bicortical pedicle screw insertion in the thoracolumbar vertebrae: analysis base on three-dimensional CT reconstruction of patients in the prone position
por: Xu, Chao, et al.
Publicado: (2020)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Cryptotanshinone Suppressed Postmenopausal Osteoporosis by Preventing RANKL-Mediated Osteoclastogenesis against Kidney Injury
por: Yang, Wenjiu, et al.
Publicado: (2022)

Deletion analysis of SMN and NAIP genes in Tunisian patients with spinal muscular atrophy
por: Rekik, Imen, et al.
Publicado: (2013)

The Importance of Digging into the Genetics of SMN Genes in the Therapeutic Scenario of Spinal Muscular Atrophy
por: Costa-Roger, Mar, et al.
Publicado: (2021)

Adult-Onset Spinal Muscular Atrophy due to Mutations in the VRK1 Gene
por: Sung, Angela, et al.
Publicado: (2021)

Gene therapy-based strategies for spinal muscular atrophy—an Asia-Pacific perspective
por: Farrar, Michelle A., et al.
Publicado: (2023)

“Guilt by Association” Is the Exception Rather Than the Rule in Gene Networks
por: Gillis, Jesse, et al.
Publicado: (2012)

Optimal Function Prediction of Key Aberrant Genes in Early-onset Preeclampsia Using a Modified Network-based Guilt by Association Method
por: WANG, Jing, et al.
Publicado: (2018)

Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy
por: Lusakowska, Anna, et al.
Publicado: (2021)

The Spinal Muscular Atrophy Disease Protein SMN Is Linked to the Golgi Network
por: Ting, Chen-Hung, et al.
Publicado: (2012)

European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy
por: Kirschner, Janbernd, et al.
Publicado: (2020)

Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
por: Kotulska, Katarzyna, et al.
Publicado: (2021)

Social Media as a Source of Knowledge about Gene Therapy for Spinal Muscular Atrophy
por: Tkaczuk, Magdalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bu71mcvliu0801e95863s08oon